Prescription Required
Authentic Product
India's Leading Generic Pharmacy
Secure Payment
By JOHNSON & JOHNSON
MRP
₹
76218
₹65000
14.72 % OFF
Check Delivery
--
Composition
Like all medications, TECVAYLI 30MG/3ML INJECTION can cause side effects, although not everyone who takes it will experience them.
Pregnancy
UNSAFETECVAYLI 30MG/3ML INJECTION is not safe for use during pregnancy because it can harm the developing baby.
Tecvayli (teclistamab) is available as a 30 mg/mL solution for intravenous infusion. The typical dosing involves an initial infusion of 1.5 mg/kg, followed by maintenance infusions of 1.5 mg/kg every two weeks. Always follow the specific dosing schedule advised by your healthcare provider.
No, TECVAYLI 30MG/3ML INJECTION is not a type of chemotherapy. While both Tecvayli and chemotherapy drugs are used to treat multiple myeloma, they work differently. Tecvayli is a monoclonal antibody that targets specific proteins on cancer cells, whereas chemotherapy drugs generally work by killing rapidly dividing cells.
TECVAYLI 30MG/3ML INJECTION was approved by the U.S. Food and Drug Administration (FDA) on October 18, 2022.
Yes, Tecvayli (teclistamab) is considered a hazardous drug. It can cause serious side effects, such as cytokine release syndrome and neurological toxicities, which require careful handling and administration. Healthcare professionals should follow proper safety protocols when administering and handling this medication.
It is important to inform your doctor about all medications, supplements, and herbal products you are currently taking. TECVAYLI 30MG/3ML INJECTION may interact with other drugs, potentially affecting how they work or increasing the risk of side effects. Your doctor will review your current medications to ensure safe use.
If you are undergoing any laboratory tests, inform your doctor that you are receiving TECVAYLI 30MG/3ML INJECTION. This medication may affect your laboratory results or the interpretation of certain tests. TECVAYLI may also cause neurological symptoms such as confusion or dizziness. Report any new symptoms or changes in your condition to your doctor without delay.
TECVAYLI 30MG/3ML INJECTION is made using the molecule TECLISTAMAB.
TECVAYLI 30MG/3ML INJECTION is used to treat multiple myeloma, a type of blood cancer.
Yes, TECVAYLI 30MG/3ML INJECTION is an anti-cancer therapy, specifically a type of immunotherapy used to treat multiple myeloma.
Amazing service and customer friendly
Deepak Patel
•
Reviewed on 05-11-2022
(3/5)
Excellent service & approach
Raju Palkhade
•
Reviewed on 18-01-2024
(5/5)
Excellent Customer service
Ashish Makwana
•
Reviewed on 12-01-2024
(5/5)
It's good work and always best treatment and every time attend coustomer properly and perfectly
Shraddha Landge
•
Reviewed on 23-01-2024
(5/5)
Good experience with best medicine purchase at affordablee prices.
Aman Rohit M
•
Reviewed on 05-02-2024
(5/5)
JOHNSON & JOHNSON
Country of Origin -
India
MRP
₹
76218
₹65000
14.72 % OFF
Quick Links
Medkart's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, medicines, generic alternatives, all possible side effects, drug interactions, warnings, alerts, lab tests, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.
10 Lakh+
Happy customers
35000+
Pin-codes Covered
75 Lakh+
Orders Delivered
Authentic Products
All WHO-GMP Certified Medicines
©2025 Medkart Pharmacy. All Rights Reserved